This result is concordant with the fact that p53 is mutated only in 10–30% of bladder cancer cases and is rarely mutated in kidney cancer (Tomasino et al, 1994; Berggren et al, 2001; Lorenzo Romero et al, 2004). Here, TP53 is linked to urinary bladder carcinoma.